NCT01197170 2021-01-22Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceM.D. Anderson Cancer CenterPhase 1 Completed277 enrolled